What is Embecta Corp.'s SG&A?

Embecta Corp. (EMBC) reported SG&A of $76.2M in Q1 2026.

How has Embecta Corp.'s SG&A changed year-over-year?

Embecta Corp.'s SG&A decreased by 4.3% year-over-year, from $79.6M to $76.2M.

What is the long-term trend for Embecta Corp.'s SG&A?

Over 4 years (2021 to 2025), Embecta Corp.'s SG&A has grown at a 8.4% compound annual growth rate (CAGR), from $240.3M to $332M.

Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.

Embecta Corp. EMBC SG&A

SG&A at other companies

InsuletPODD

$317.2M+21.7%

Tandem Diabetes CareTNDM

$108.19M-5.0%

MedtronicMDT

$3.06B+12.4%

Lifecore Biomedical, Inc.LFCR

$7.92M-11.8%

MannkindMNKD

$54.09M+116%

ICU MedicalICUI

$154.57M-1.7%

Other financials

Income statement

See full

Revenue$221.8M-14.4%

Gross profit$127.8M-22.1%

Operating income$35.0M-44.4%

Net income-$4.1M-117%

EPS (diluted)-$0.07-118%

Balance sheet

See full

Cash & equivalents$193.4M-8.9%

Total debt$1.4B-12.5%

Total equity-$626.1M+15.0%

Total assets$1.0B-8.1%

Cash flow

See full

Operating cash flow$31.1M-2.2%

CapEx$500.0K+400%

Free cash flow$30.6M-3.5%

Valuation

See full

Market cap$193.41M-64.3%

Enterprise value$1.37B-24.8%

P/E1.7×-4.8×

P/S0.2×-0.3×

Profitability

See full

Gross margin61.9%-1.6pp

Operating margin25.8%+9.7pp

Net margin10.7%+5.8pp

FCF margin19.6%+16.0pp

Returns & leverage

See full

Return on equity71.9%—

Debt / equity0×—

Current ratio2.5×0.0×

Where this comes from

Reported directly by Embecta Corp. in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The official record: Embecta Corp.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Embecta Corp.'s sg&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Embecta Corp.'s SG&A?: Embecta Corp. (EMBC) reported SG&A of $76.2M in Q1 2026.
How has Embecta Corp.'s SG&A changed year-over-year?: Embecta Corp.'s SG&A decreased by 4.3% year-over-year, from $79.6M to $76.2M.
What is the long-term trend for Embecta Corp.'s SG&A?: Over 4 years (2021 to 2025), Embecta Corp.'s SG&A has grown at a 8.4% compound annual growth rate (CAGR), from $240.3M to $332M.
What does SG&A mean?: Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.